MPX International Corporation

OTCPK:MPXO.F Stock Report

Market Cap: US$28.9k

MPX International Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on MPX International's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Mar 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How MPX International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MPXO.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 227-28140
31 Dec 217-29140
30 Sep 217-27130
30 Jun 217-41150
31 Mar 216-45140
31 Dec 204-39140
30 Sep 203-41160
30 Jun 203-15160
31 Mar 203-11160
31 Dec 192-12160
30 Sep 192-9120
30 Jun 191-880
31 Mar 191-760
31 Dec 180-330
30 Sep 180-220
30 Jun 180-110
31 Mar 180-110

Quality Earnings: Insufficient data to determine if MPXO.F has high quality earnings.

Growing Profit Margin: Insufficient data to determine if MPXO.F's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MPXO.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare MPXO.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if MPXO.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.


Return on Equity

High ROE: MPXO.F has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies